Related Experiment Video
Updated: Apr 6, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway
Abstract:
This study aimed to examine the effect of long non-coding RNA (LncRNA) MEG3 on the biological behaviors of renal cell carcinoma (RCC) cells 786-0 and the possible mechanism. MEG3 expression levels were detected by RT-qPCR in tumor tissues and adjacent non-tumor tissues from 29 RCC patients and in RCC lines 786-0 and SN12 and human embryonic kidney cell line 293T. Plasmids GV144-MEG3 (MEG3 overexpression plasmid) and GV144 (control plasmid) were stably transfected into 786-0 cells by using lipofectamine 2000. Cell viabilities were determined by MTT, cell apoptosis rates by flow cytometry following PE Annexin V and 7AAD staining, apoptosis-related protein expressions by Western blotting, and Bcl-2 mRNA by RT-qPCR in the transfected cells. The results showed that MEG3 was evidently downregulated in RCC tissues (P<0.05) and RCC cell lines (P<0.05). The viabilities of 786-0 cells were decreased significantly after transfection with GV144-MEG3 for over 24 h (P<0.05). Consistently, the apoptosis rate was significantly increased in 786-0 cells transfected with GV144-MEG3 for 48 h (P<0.05). Furthermore, overexpression of MEG3 could reduce the expression of Bcl-2 and procaspase-9 proteins, enhance the expression of cleaved caspase-9 protein, and promote the release of cytochrome c protein to cytoplasm (P<0.05). Additionally, Bcl-2 mRNA level was declined by MEG3 overexpression (P<0.05). It was concluded that MEG3 induces the apoptosis of RCC cells possibly by activating the mitochondrial pathway.
Insights
Long non-coding RNA MEG3 is downregulated in renal cell carcinoma (RCC). Overexpressing MEG3 inhibits RCC cell viability and promotes apoptosis, suggesting therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
Background:
- Renal cell carcinoma (RCC) is a significant health concern.
- Long non-coding RNAs (LncRNAs) play crucial roles in cancer development.
- The role of LncRNA MEG3 in RCC requires further investigation.
Purpose of the Study:
- To investigate the effect of LncRNA MEG3 on the biological behaviors of RCC cells.
- To elucidate the underlying mechanism of MEG3's action in RCC.
Main Methods:
- MEG3 expression was quantified using RT-qPCR in RCC tissues and cell lines.
- MEG3 was overexpressed in 786-0 RCC cells via plasmid transfection.
- Cell viability, apoptosis rates, and protein/mRNA expression (Bcl-2, caspase-9, cytochrome c) were assessed.
Main Results:
- MEG3 expression was significantly downregulated in RCC tissues and cell lines.
- MEG3 overexpression reduced 786-0 cell viability and increased apoptosis.
- MEG3 overexpression affected apoptosis-related proteins and Bcl-2 mRNA levels, indicating mitochondrial pathway activation.
Conclusions:
- LncRNA MEG3 is downregulated in RCC.
- MEG3 induces apoptosis in RCC cells, likely through the mitochondrial pathway.
- MEG3 may serve as a potential therapeutic target for RCC.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

